Vial

INDIVIDUAL TEST 090

Islet Cell Antibodies

Indication

Suspicion of type 1 diabetes (T1D)

Sample material

Serum

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: room temperature
  • International: room temperature

Method

Indirect immunofluorescence (IIF)

Reference interval

<1:5 negative

Result

Results are reported as negative or positive with a titer.

Interpretation

Approximately 70-90% of patients diagnosed with T1D, are positive for antibodies against Islet cells. Antibodies can be detected several years before diagnosis and are a strong predictor of future development of insulin-dependent diabetes mellitus (IDDM).

Islet cell antibodies comprise of a heterogeneous group of antibodies that are directed against glutamic acid decarboxylase (GAD65), tyrosine phosphatase-related islet cell antigen 2 (IA-2), zinc transport protein ZnT8, and other untill now unknown antigens.

References

  • Hill TG, Hill DJ. Int J Mol Sci. 2024 The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes. PMID: 38612880
  • Joglekar MV et al. Lancet Diabetes Endocrinol. 2024 Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores. PMID: 38797187
  • Phillip M et al. Diabetes Care. 2024. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. PMID: 38912694

Last updated: 2025-11-19

More information

Learn more about sampling.
> Read more

Download request forms

Autoimmune diagnostics

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 090

Ö-cells-antikroppar

Indikation

Misstanke om typ 1 diabetes (T1D)

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Transport

  • Inom Sverige: rumstemperatur
  • Internationellt: kylt

Metod

Indirekt immunofluorescens (IIF)

Referensintervall

< 1:5 negativt

Resultat

Resultat anges som negativt eller positivt med titer.

Tolkning

Vid diagnos av T1D kan antikroppar mot Langerhanska ö-celler påvisas hos 70–90% av patienterna. Antikropparna kan förekomma flera år före diagnos och är en stark prediktor för framtida utveckling av insulinberoende diabetes mellitus (IDDM).

Ö-cellsantikroppar utgörs av en heterogen grupp av antikroppar som kan vara riktade mot glutaminsyradekarboxylas (GAD65), tyrosinfosfatas relaterat ö-cellsantigen 2 (IA-2), zinktransport proteinet ZnT8 och andra hittills okända antigen.

Referenser

  • Hill TG, Hill DJ. Int J Mol Sci. 2024 The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes. PMID: 38612880
  • Joglekar MV et al. Lancet Diabetes Endocrinol. 2024 Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores. PMID: 38797187
  • Phillip M et al. Diabetes Care. 2024. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. PMID: 38912694

Senast uppdaterat: 2025-11-19

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Autoimmun diagnostik

Hittar du inte vad du söker? Vi kan hjälpa till